Durham, NC, United States of America

Heeren M Gordhan

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Alcon, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heeren M Gordhan. Retrieved from https://idiyas.com/inventor/heeren-m-gordhan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Heeren M Gordhan: Innovator in Therapeutic Compounds

Introduction

Heeren M Gordhan is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of therapeutic agents through his innovative research and development.

Latest Patents

Heeren M Gordhan holds 1 patent for his work on "Heterobicyclic carboxamides and uses thereof." This patent includes the development of heterobicyclic cyclopropanecarboxamide and heterobicyclic carboxamide compounds. These compounds are designed to affect the function of kinases in a cell, making them useful as therapeutic agents. They have potential applications in treating various diseases and conditions, including eye diseases such as glaucoma, cardiovascular diseases, inflammatory diseases, and cancers characterized by abnormal growth.

Career Highlights

Heeren M Gordhan is associated with Alcon, Inc., where he continues to advance his research in therapeutic compounds. His work has the potential to impact the treatment of several serious health conditions.

Collaborations

He has collaborated with notable coworkers, including Mitchell A Delong and Jill M Sturdivant, contributing to a dynamic research environment.

Conclusion

Heeren M Gordhan's innovative work in the field of therapeutic compounds showcases his commitment to improving health outcomes through scientific advancements. His contributions are paving the way for new treatments for various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…